[Form 4] HeartBeam, Inc. Insider Trading Activity
Rhea-AI Filing Summary
HeartBeam, Inc. (BEAT) CFO Tim Cruickshank reported a Form 4 showing a sale of 17,647 shares of Common Stock and a grant of 23,333 Restricted Stock Units (RSUs) on 09/30/2025. The RSUs were issued under the company’s 2022 Equity Incentive Plan and vest in two equal tranches: one half on the three‑month anniversary of the vesting commencement date (July 1, 2025 start) and the remainder on the six‑month anniversary. The filing notes RSUs do not expire and are either vested or canceled. The report was signed by the reporting person on 10/03/2025.
Positive
- 23,333 RSUs granted under the 2022 Equity Incentive Plan, aligning executive compensation with shareholders
- RSU vesting schedule is time‑based with clear dates (three‑ and six‑month anniversaries), providing transparency
Negative
- 17,647 shares disposed by the CFO, representing an insider sale disclosed on Form 4
- Immediate insider sale and near‑term vesting could increase free float in the short term
Insights
TL;DR: CFO sold 17,647 shares and received 23,333 RSUs vesting over 3–6 months.
The Form 4 documents two distinct actions: a disposal of 17,647 common shares and a grant of 23,333 RSUs under the 2022 Equity Incentive Plan. The RSUs vest in two equal installments tied to a vesting commencement date of July 1, 2025, with no listed expiration.
This filing is material to shareholders because it records immediate insider selling and a near‑term equity compensation schedule for a senior officer; both items are factual disclosures required by Section 16 and may affect short‑term share count and insider ownership disclosure.